CeriBell (CBLL) Competitors $11.42 -0.41 (-3.47%) Closing price 09/2/2025 04:00 PM EasternExtended Trading$11.43 +0.01 (+0.09%) As of 09/2/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. CNMD, NVCR, SSII, ESTA, CDRE, BLFS, PLSE, MDXG, KMTS, and INMDShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include CONMED (CNMD), NovoCure (NVCR), SS Innovations International (SSII), Establishment Labs (ESTA), Cadre (CDRE), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), MiMedx Group (MDXG), Kestra Medical Technologies (KMTS), and InMode (INMD). These companies are all part of the "medical equipment" industry. CeriBell vs. Its Competitors CONMED NovoCure SS Innovations International Establishment Labs Cadre BioLife Solutions Pulse Biosciences MiMedx Group Kestra Medical Technologies InMode CeriBell (NASDAQ:CBLL) and CONMED (NYSE:CNMD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends. Is CBLL or CNMD more profitable? CONMED has a net margin of 8.31% compared to CeriBell's net margin of -63.83%. CONMED's return on equity of 14.43% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBell-63.83% -48.42% -28.50% CONMED 8.31%14.43%6.05% Which has preferable earnings & valuation, CBLL or CNMD? CONMED has higher revenue and earnings than CeriBell. CeriBell is trading at a lower price-to-earnings ratio than CONMED, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M6.40-$40.46M-$2.99-3.82CONMED$1.31B1.27$132.42M$3.5315.15 Does the media refer more to CBLL or CNMD? In the previous week, CONMED had 3 more articles in the media than CeriBell. MarketBeat recorded 10 mentions for CONMED and 7 mentions for CeriBell. CONMED's average media sentiment score of 1.10 beat CeriBell's score of 0.69 indicating that CONMED is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CBLL or CNMD? CeriBell currently has a consensus price target of $32.14, suggesting a potential upside of 181.46%. CONMED has a consensus price target of $59.80, suggesting a potential upside of 11.84%. Given CeriBell's stronger consensus rating and higher possible upside, equities analysts clearly believe CeriBell is more favorable than CONMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20 SummaryCONMED beats CeriBell on 9 of the 13 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$433.73M$10.90B$5.74B$9.77BDividend YieldN/A1.84%6.66%4.50%P/E Ratio-3.8221.6183.1926.39Price / Sales6.4031.30532.40110.52Price / CashN/A25.1325.7028.92Price / Book2.433.4511.096.58Net Income-$40.46M$211.94M$3.28B$265.84M7 Day Performance-1.55%-0.78%-0.21%-0.26%1 Month Performance-19.24%13.38%8.31%5.82%1 Year PerformanceN/A-7.31%54.52%22.47% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.5696 of 5 stars$11.42-3.5%$32.14+181.5%N/A$433.73M$65.44M-3.82N/ACNMDCONMED4.5498 of 5 stars$54.35-2.6%$59.80+10.0%-27.0%$1.73B$1.33B15.403,900Positive NewsNVCRNovoCure3.9942 of 5 stars$11.70-5.9%$28.79+146.0%-37.3%$1.39B$605.22M-7.501,488News CoverageSSIISS Innovations InternationalN/A$6.98-0.1%N/AN/A$1.35B$27.62M0.004Positive NewsGap UpESTAEstablishment Labs2.0933 of 5 stars$40.66-6.8%$56.50+39.0%-12.0%$1.26B$177.42M-13.331,018News CoveragePositive NewsCDRECadre3.4031 of 5 stars$30.27-2.5%$31.50+4.0%-14.8%$1.26B$567.56M32.212,284Positive NewsBLFSBioLife Solutions1.7852 of 5 stars$25.65-1.0%$31.29+22.0%-2.1%$1.24B$82.25M-213.73440PLSEPulse Biosciences4.0244 of 5 stars$16.49-3.3%$22.00+33.4%-18.9%$1.15B$700K-15.70140News CoveragePositive NewsMDXGMiMedx Group3.4548 of 5 stars$7.08-3.1%$12.00+69.5%+5.1%$1.08B$348.88M33.72870News CoveragePositive NewsKMTSKestra Medical Technologies1.3842 of 5 stars$17.72-4.6%$27.33+54.3%N/A$953.80M$59.81M0.00300News CoveragePositive NewsLockup ExpirationINMDInMode3.8062 of 5 stars$14.57-1.6%$18.04+23.8%-13.8%$936.13M$394.82M5.90480Positive News Related Companies and Tools Related Companies CONMED Alternatives NovoCure Alternatives SS Innovations International Alternatives Establishment Labs Alternatives Cadre Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives MiMedx Group Alternatives Kestra Medical Technologies Alternatives InMode Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBLL Stock Alerts